Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLG
2401
DELISTED
WK Kellogg Co
KLG
| $26.6M | ﹤0.01% |
1,336,819
-129,476
| -9% | -$2.36M |
|
2402
Kilroy Realty
KRC
$4.32B
| $26.6M | ﹤0.01% |
812,922
-334,157
| -29% | -$12M |
|
2403
Enovix
ENVX
$1.01B
| $26.6M | ﹤0.01% |
4,143,467
-121,060
| -3% | -$1.08M |
|
2404
LiveRamp
RAMP
$2.3B
| $26.6M | ﹤0.01% |
1,017,271
-151,398
| -13% | -$4.63M |
|
2405
Recursion Pharmaceuticals
RXRX
$1.76B
| $26.5M | ﹤0.01% |
5,010,433
+2,149,906
| +75% | +$15.7M |
|
|
KKR.PRD
2406
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.31B
| $26.5M | ﹤0.01% |
+536,153
| New | +$26.4M |
|
2407
Invesco Financial Preferred ETF
PGF
$667M
| $26.5M | ﹤0.01% |
1,854,646
-15,125
| -0.8% | -$222K |
|
2408
Dave & Buster's
PLAY
$343M
| $26.5M | ﹤0.01% |
1,506,768
-17,437
| -1% | -$413K |
|
2409
CEVA Inc
CEVA
$889M
| $26.5M | ﹤0.01% |
1,033,641
+220,314
| +27% | +$7.08M |
|
2410
Photronics
PLAB
$1.89B
| $26.4M | ﹤0.01% |
1,272,450
+55,738
| +5% | +$1.24M |
|
|
EOS
2411
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
| $26.4M | ﹤0.01% |
1,250,183
-46,145
| -4% | -$1.08M |
|
2412
Gerdau
GGB
$9.74B
| $26.3M | ﹤0.01% |
9,275,886
-9,583,393
| -51% | -$28M |
|
|
OPLN
2413
Openlane
OPLN
$4.58B
| $26.3M | ﹤0.01% |
1,364,551
+389,831
| +40% | +$8.05M |
|
2414
Westlake Corp
WLK
$10.1B
| $26.3M | ﹤0.01% |
262,556
-38,994
| -13% | -$4.32M |
|
2415
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$600M
| $26.3M | ﹤0.01% |
350,671
-18,815
| -5% | -$1.51M |
|
2416
Sensient Technologies
SXT
$5.51B
| $26.2M | ﹤0.01% |
352,247
-48,456
| -12% | -$3.53M |
|
2417
Pricesmart
PSMT
$5.21B
| $26.2M | ﹤0.01% |
298,426
+25,528
| +9% | +$2.27M |
|
2418
Insperity
NSP
$1.96B
| $26.2M | ﹤0.01% |
293,693
-65,416
| -18% | -$5.43M |
|
2419
Avient
AVNT
$4.19B
| $26.2M | ﹤0.01% |
705,225
-167,756
| -19% | -$6.94M |
|
2420
SiteOne Landscape Supply
SITE
$4.34B
| $26.2M | ﹤0.01% |
215,725
+6,712
| +3% | +$890K |
|
2421
Fresenius Medical Care
FMS
$13B
| $26.2M | ﹤0.01% |
1,050,684
+15,725
| +2% | +$374K |
|
2422
Invesco NASDAQ Internet ETF
PNQI
$545M
| $26.2M | ﹤0.01% |
592,674
-3,629
| -0.6% | -$173K |
|
2423
Alight
ALIT
$394M
| $26.1M | ﹤0.01% |
220,403
+69,924
| +46% | +$9.2M |
|
2424
Invesco BulletShares 2033 Corporate Bond ETF
BSCX
$1.03B
| $26.1M | ﹤0.01% |
1,250,403
+386,368
| +45% | +$8.01M |
|
2425
Stepan Co
SCL
$1.47B
| $26.1M | ﹤0.01% |
474,514
-38,078
| -7% | -$2.32M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.